The Swiss drugmaker has plucked an experienced scientist from Down Under to lead its early research efforts. Hematologist Mark Dawson, M.D., Ph.D., an expert in cancer epigenetics, will now head up Roche’s pharma research and early development unit, effective May 1.
- Home |
- Chutes & Ladders—Roche taps Aussie oncologist to lead early research
Chutes & Ladders—Roche taps Aussie oncologist to lead early research
- February 19, 2026
Recent Posts
- Oil jumps 5% as Hormuz tanker attacks escalate, US Gulf hurricane shuts in production
- Crescent Energy to acquire Eagle Ford assets from Devon for $4.2 billion
- LNG market tightens into winter as Europe pulls US cargoes, China reopens contract talks
- EIA: US crude oil inventories down 3.2 million bbl
- Chevron restructures Bakken midstream agreements, transfers Hess Midstream stake
